Literature DB >> 22576802

MTA1 gene silencing inhibits invasion and alters the microRNA expression profile of human lung cancer cells.

Xiaoxia Zhu1, Xiao Zhang, Haofei Wang, Qingcui Song, Gong Zhang, Lei Yang, Jian Geng, Xiangzhao Li, Yawei Yuan, Longhua Chen.   

Abstract

Metastasis-associated gene 1 (MTA1) is involved in the carcinogenesis and metastasis of many human carcinomas. However, its exact role in non-small cell lung cancer (NSCLC) is still unclear. Using immunohistochemistry analysis, we recently identified MTA1 to be associated with the progression of NSCLC. Here, we carried out further analysis on the effect of MTA1 knockdown in an NSCLC cell line on cell functions and the global microRNA (miRNA) expression profile. We succeeded in establishing the MTA1 knockdown NSCLC cell line using RNA interference (RNAi), and found that the silencing of MTA1 resulted in the effective inhibition of the invasive ability of NSCLC cells, but not of the cell growth in vitro. We performed an miRNA microarray analysis and demonstrated for the first time that MTA1 knockdown significantly changed the expression of some miRNAs in NSCLC cells. Among them, some have a well-characterized association with cancer progression, e.g. miR-125b, miR-210, miR-103, miR-194 and miR-500. In summary, it is evident from our results that MTA1 functions in regulating the invasive phenotype of lung cancer cells and this regulation may be through altered miRNA expression. The interaction between MTA1 and the miRNAs which contributes to lung cancer is worthy of further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22576802     DOI: 10.3892/or.2012.1770

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

Review 1.  Post-transcriptional regulation of MTA family by microRNAs in the context of cancer.

Authors:  Yun Zhang; Xiao-Fan Wang
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

Review 2.  Structure, expression and functions of MTA genes.

Authors:  Rakesh Kumar; Rui-An Wang
Journal:  Gene       Date:  2016-02-09       Impact factor: 3.688

3.  MiR-744 Functions as an Oncogene Through Direct Binding to c-Fos Promoter and Facilitates Non-small Cell Lung Cancer Progression.

Authors:  Shangbiao Li; Simiao Qiao; Na Li; Xiaoxia Zhu
Journal:  Ann Surg Oncol       Date:  2021-10-01       Impact factor: 5.344

4.  Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway.

Authors:  Yimin Lu; Changjiang Wei; Zhaoqing Xi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-18       Impact factor: 2.416

5.  Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro.

Authors:  Xiao-yan Gu; Jun Wang; Yi-zhou Luo; Qiang Du; Ruo-ran Li; Hui Shi; Tian-pei Yu
Journal:  Tumour Biol       Date:  2014-02-16

6.  MicroRNA-103a-3p controls proliferation and osteogenic differentiation of human adipose tissue-derived stromal cells.

Authors:  Da Sol Kim; Sun Young Lee; Jung Hee Lee; Yong Chan Bae; Jin Sup Jung
Journal:  Exp Mol Med       Date:  2015-07-10       Impact factor: 8.718

7.  Mining featured micro ribonucleic acids associated with lung cancer based on bioinformatics.

Authors:  Lin Su; Na Li; Xueyun Huo
Journal:  Thorac Cancer       Date:  2015-07-02       Impact factor: 3.500

8.  MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.

Authors:  Yuan Fang; Xiaoxia Zhu; Jian Wang; Na Li; Dianhe Li; Nazmus Sakib; Zhou Sha; Wen Song
Journal:  Oncotarget       Date:  2015-05-30

9.  MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b.

Authors:  Yiyi Li; Yilan Chao; Yuan Fang; Jian Wang; Min Wang; Hong Zhang; Min Ying; Xiaoxia Zhu; Haofei Wang
Journal:  J Exp Clin Cancer Res       Date:  2013-05-29

10.  MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo.

Authors:  Qingcui Song; Hong Zhang; Min Wang; Wen Song; Min Ying; Yuan Fang; Yiyi Li; Yilan Chao; Xiaoxia Zhu
Journal:  J Exp Clin Cancer Res       Date:  2013-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.